Protocol for the development of a core outcome set for clinical trials in primary sclerosing cholangitis
Background Primary sclerosing cholangitis (PSC) is a progressive immune-mediated liver disease, for which no medical therapy has been shown to slow disease progression. However, the horizon for new therapies is encouraging, with several innovative clinical trials in progress. Despite these advanceme...
Główni autorzy: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Artykuł |
Język: | English |
Wydane: |
BMJ Publishing Group
2024-06-01
|
Seria: | BMJ Open |
Dostęp online: | https://bmjopen.bmj.com/content/14/6/e080143.full |